Blog
TREM2: Exploring Its Role in Tumor-Associated Macrophages and Cancer Immunotherapy
Introduction to TREM2 and Tumor-Associated Macrophages in CancerTREM2 (triggering receptor expressed on myeloid cells 2) is an immunoregulatory receptor primarily expressed on macrophage
…
31st Oct 2024
Dual PD-1/PD-L2 Blockade: Expanding the Horizons of Cancer Immunotherapy
Introduction to PD-1, PD-L1, and PD-L2 in Cancer ImmunotherapyThe PD-1/PD-L1 immune checkpoint pathway has been instrumental in cancer immunotherapy, with PD-1 (programmed death-1) inhib
…
29th Oct 2024
CD73: Combating Tumor Immunosuppression by Targeting Adenosine
Introduction to CD73 and Tumor Immunosuppression CD73, also known as ecto-5'-nucleotidase, is an enzyme found on the surface of various cells, including tumor cells and immune cells
…
21st Oct 2024
CD39: A Novel Target to Overcome Immunosuppression in Cancer
Introduction to CD39 and Cancer Immunosuppression CD39 is an ectonucleotidase enzyme that plays a crucial role in generating adenosine, a powerful immunosuppressive molecule within
…
21st Oct 2024
BTLA: A Key Player in Immune Regulation and Cancer Therapy
Introduction to BTLA in Immune Regulation B and T lymphocyte attenuator (BTLA) is an immune checkpoint molecule that plays a critical role in regulating immune responses by suppress
…
16th Oct 2024